547 related articles for article (PubMed ID: 35690154)
1. Association of Predicted HLA T-Cell Epitope Targets and T-Cell-Mediated Rejection After Kidney Transplantation.
Senev A; Van Loon E; Lerut E; Coemans M; Callemeyn J; Daniëls L; Kerkhofs J; Koshy P; Kuypers D; Lamarthée B; Sprangers B; Tinel C; Van Craenenbroeck AH; Van Sandt V; Emonds MP; Naesens M
Am J Kidney Dis; 2022 Dec; 80(6):718-729.e1. PubMed ID: 35690154
[TBL] [Abstract][Full Text] [Related]
2. PIRCHE-II scores prove useful as a predictive biomarker among kidney transplant recipients with rejection: An analysis of indication and follow-up biopsies.
Spitznagel T; Matter LS; Kaufmann YL; Nilsson J; von Moos S; Schachtner T
Front Immunol; 2022; 13():949933. PubMed ID: 36059499
[TBL] [Abstract][Full Text] [Related]
3. Molecular Mismatch Predicts T Cell-Mediated Rejection and De Novo Donor-Specific Antibody Formation After Living Donor Liver Transplantation.
Ono K; Ide K; Tanaka Y; Ohira M; Tahara H; Tanimine N; Yamane H; Ohdan H
Liver Transpl; 2021 Nov; 27(11):1592-1602. PubMed ID: 34310028
[TBL] [Abstract][Full Text] [Related]
4. Eplet Mismatch Load and
Senev A; Coemans M; Lerut E; Van Sandt V; Kerkhofs J; Daniëls L; Driessche MV; Compernolle V; Sprangers B; Van Loon E; Callemeyn J; Claas F; Tambur AR; Verbeke G; Kuypers D; Emonds MP; Naesens M
J Am Soc Nephrol; 2020 Sep; 31(9):2193-2204. PubMed ID: 32764139
[TBL] [Abstract][Full Text] [Related]
5. Analysis of T and B Cell Epitopes to Predict the Risk of
Sakamoto S; Iwasaki K; Tomosugi T; Niemann M; Spierings E; Miwa Y; Horimi K; Takeda A; Goto N; Narumi S; Watarai Y; Kobayashi T
Front Immunol; 2020; 11():2000. PubMed ID: 32973806
[TBL] [Abstract][Full Text] [Related]
6. Association of HLA B- and T-cell molecular mismatches with HLA antibodies, rejection, and graft survival in pediatric kidney transplantation.
Gramkow AM; Baatrup JH; Gramkow ET; Thiesson HC; Koefoed-Nielsen P
Pediatr Transplant; 2024 Aug; 28(5):e14773. PubMed ID: 38808702
[TBL] [Abstract][Full Text] [Related]
7. HLA molecular mismatches and induced donor-specific tolerance in combined living donor kidney and hematopoietic stem cell transplantation.
Senev A; Tambur AR; Kosmoliaptsis V; Copley HC; García-Sánchez C; Usenko C; Ildstad ST; Leventhal JR
Front Immunol; 2024; 15():1377535. PubMed ID: 38601147
[TBL] [Abstract][Full Text] [Related]
8. The number of donor HLA-derived T cell epitopes available for indirect antigen presentation determines the risk for vascular rejection after kidney transplantation.
Betjes MGH; Peereboom ETM; Otten HG; Spierings E
Front Immunol; 2022; 13():973968. PubMed ID: 36110856
[TBL] [Abstract][Full Text] [Related]
9. Donor-Recipient Matching Based on Predicted Indirectly Recognizable HLA Epitopes Independently Predicts the Incidence of De Novo Donor-Specific HLA Antibodies Following Renal Transplantation.
Lachmann N; Niemann M; Reinke P; Budde K; Schmidt D; Halleck F; Pruß A; Schönemann C; Spierings E; Staeck O
Am J Transplant; 2017 Dec; 17(12):3076-3086. PubMed ID: 28613392
[TBL] [Abstract][Full Text] [Related]
10. Association between PIRCHE-II scores and de novo allosensitization after reduction of immunosuppression during SARS-CoV-2 infection in kidney transplant recipients.
Castrezana-Lopez K; Malchow R; Nilsson J; Kokkonen SM; Rho E; von Moos S; Mueller TF; Schachtner T
Transpl Infect Dis; 2023 Apr; 25(2):e14052. PubMed ID: 36884207
[TBL] [Abstract][Full Text] [Related]
11. Donor/Recipient HLA Molecular Mismatch Scores Predict Primary Humoral and Cellular Alloimmunity in Kidney Transplantation.
Meneghini M; Crespo E; Niemann M; Torija A; Lloberas N; Pernin V; Fontova P; Melilli E; Favà A; Montero N; Manonelles A; Cruzado JM; Palou E; Martorell J; Grinyó JM; Bestard O
Front Immunol; 2020; 11():623276. PubMed ID: 33776988
[TBL] [Abstract][Full Text] [Related]
12. T-Cell Epitopes Shared Between Immunizing HLA and Donor HLA Associate With Graft Failure After Kidney Transplantation.
Peereboom ETM; Matern BM; Tomosugi T; Niemann M; Drylewicz J; Joosten I; Allebes WA; van der Meer A; Hilbrands LB; Baas MC; van Reekum FE; Verhaar MC; Kamburova EG; Seelen MAJ; Sanders JS; Hepkema BG; Lambeck AJ; Bungener LB; Roozendaal C; Tilanus MGJ; Voorter CE; Wieten L; van Duijnhoven EM; Gelens MACJ; Christiaans MHL; van Ittersum FJ; Nurmohamed A; Lardy NM; Swelsen W; van der Pant KA; van der Weerd NC; Ten Berge IJM; Bemelman FJ; de Vries APJ; de Fijter JW; Betjes MGH; Roelen DL; Claas FH; Otten HG; Heidt S; van Zuilen AD; Kobayashi T; Geneugelijk K; Spierings E
Front Immunol; 2021; 12():784040. PubMed ID: 34868064
[TBL] [Abstract][Full Text] [Related]
13. Eplet mismatch analysis and allograft outcome across racially diverse groups in a pediatric transplant cohort: a single-center analysis.
Philogene MC; Amin A; Zhou S; Charnaya O; Vega R; Desai N; Neu AM; Pruette CS
Pediatr Nephrol; 2020 Jan; 35(1):83-94. PubMed ID: 31599339
[TBL] [Abstract][Full Text] [Related]
14. Class II HLA Eplet Mismatch Is a Risk Factor for De Novo Donor-Specific Antibody Development and Antibody-mediated Rejection in Kidney Transplantation Recipients.
Kishikawa H; Kinoshita T; Hashimoto M; Fukae S; Taniguchi A; Yamanaka K; Nakagawa M; Nishimura K
Transplant Proc; 2018 Oct; 50(8):2388-2391. PubMed ID: 30316363
[TBL] [Abstract][Full Text] [Related]
15. Association of HLA Mismatches and Histology Suggestive of Antibody-Mediated Injury in the Absence of Donor-Specific Anti-HLA Antibodies.
Senev A; Lerut E; Coemans M; Callemeyn J; Copley HC; Claas F; Koshy P; Kosmoliaptsis V; Kuypers D; Sprangers B; Van Craenenbroeck A; Van Loon E; Van Sandt V; Emonds MP; Naesens M
Clin J Am Soc Nephrol; 2022 Aug; 17(8):1204-1215. PubMed ID: 35649719
[TBL] [Abstract][Full Text] [Related]
16. Epitopes as characterized by antibody-verified eplet mismatches determine risk of kidney transplant loss.
Sapir-Pichhadze R; Zhang X; Ferradji A; Madbouly A; Tinckam KJ; Gebel HM; Blum D; Marrari M; Kim SJ; Fingerson S; Bashyal P; Cardinal H; Foster BJ
Kidney Int; 2020 Apr; 97(4):778-785. PubMed ID: 32059998
[TBL] [Abstract][Full Text] [Related]
17. Eplet matching in pediatric heart transplantation: The SickKids experience.
Cardoso B; Wang J; Kiernan J; Dipchand AI
J Heart Lung Transplant; 2022 Oct; 41(10):1470-1477. PubMed ID: 35933296
[TBL] [Abstract][Full Text] [Related]
18. PIRCHE-II Is Related to Graft Failure after Kidney Transplantation.
Geneugelijk K; Niemann M; Drylewicz J; van Zuilen AD; Joosten I; Allebes WA; van der Meer A; Hilbrands LB; Baas MC; Hack CE; van Reekum FE; Verhaar MC; Kamburova EG; Bots ML; Seelen MAJ; Sanders JS; Hepkema BG; Lambeck AJ; Bungener LB; Roozendaal C; Tilanus MGJ; Vanderlocht J; Voorter CE; Wieten L; van Duijnhoven EM; Gelens M; Christiaans MHL; van Ittersum FJ; Nurmohamed A; Lardy JNM; Swelsen W; van der Pant KA; van der Weerd NC; Ten Berge IJM; Bemelman FJ; Hoitsma A; van der Boog PJM; de Fijter JW; Betjes MGH; Heidt S; Roelen DL; Claas FH; Otten HG; Spierings E
Front Immunol; 2018; 9():321. PubMed ID: 29556227
[TBL] [Abstract][Full Text] [Related]
19. Human leukocyte antigen epitope mismatch loads and the development of de novo donor-specific antibodies in cardiothoracic organ transplantation.
Bedford A; Jervis S; Worthington J; Lowe M; Poulton K
Int J Immunogenet; 2022 Feb; 49(1):30-38. PubMed ID: 34904369
[TBL] [Abstract][Full Text] [Related]
20. Can PIRCHE-II Matching Outmatch Traditional HLA Matching?
Unterrainer C; Döhler B; Niemann M; Lachmann N; Süsal C
Front Immunol; 2021; 12():631246. PubMed ID: 33717167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
